24 Oct Lucigen to License Epicentre Products
Lucigen is licensing Epicentre’s entire product portfolio from Illumina, the company announced recently.
According to a release, Lucigen now has exclusive rights to manufacture and sell Epicentre products through its worldwide distribution network. Illumina acquired Madison-based Epicentre in 2011.
“We are excited to be able to offer this complete line of genomics products to researchers,” Lucigen President Jeff Williams said in a statement. “A combined Lucigen and Epicentre product portfolio provides a broad set of unique tools that deliver innovation and ease of use to life scientists.”
Sorry, the comment form is closed at this time.